Overview

Spironolactone for Hidradenitis Suppurativa

Status:
Withdrawn
Trial end date:
2021-06-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if the drug spironolactone - which is used to treat acne and male pattern hair growth in women - is effective in treating hidradenitis suppurativa in females and which dose of the drug works the best. Participation in this study will take about 4 clinic visits over approximately 7 months with the option to continue for longer if desired.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of South Carolina
Treatments:
Spironolactone